Tata V - Search Results

1

Differences in Perceived Threat and Efficacy in Managing Opioid Use Disorder versus Alcohol Use Disorder.

Tata V, Majd Z, Talwar A, Bapat S, Cruz A, Essien JE, Thornton JD. Tata V, et al. Subst Use Misuse. 2023;58(10):1187-1195. doi: 10.1080/10826084.2023.2212075. Epub 2023 Jun 4. Subst Use Misuse. 2023. PMID: 37271735

2

Differences between pharmacists' perception of counseling and practice in the era of prescription drug misuse.

Thornton JD, Anyanwu P, Tata V, Al Rawwad T, Fleming ML. Thornton JD, et al. Among authors: tata v. Pharm Pract (Granada). 2020 Jan-Mar;18(1):1682. doi: 10.18549/PharmPract.2020.1.1682. Epub 2020 Feb 24. Pharm Pract (Granada). 2020. PMID: 32206140 Free PMC article.

3

Barriers and Facilitators to DATA Waivered Providers Prescribing Buprenorphine: A Qualitative Analysis Applying the Theory of Planned Behavior.

Bapat S, Washburn M, Tata V, Fleming M, Abughosh SM, Essien EJ, Thornton D. Bapat S, et al. Among authors: tata v. Subst Use Misuse. 2022;57(12):1761-1771. doi: 10.1080/10826084.2022.2112226. Epub 2022 Aug 21. Subst Use Misuse. 2022. PMID: 35993387

4

Physician perspective on the implementation of risk mitigation strategies when prescribing opioid medications: a qualitative analysis.

Tata V, Al Saadi R, Cho SK, Varisco TJ, Wanat M, Thornton JD. Tata V, et al. BMC Health Serv Res. 2023 Oct 31;23(1):1185. doi: 10.1186/s12913-023-10136-z. BMC Health Serv Res. 2023. PMID: 37907915 Free PMC article.

5

Clinical decision making involving prescription drug monitoring programs: A factorial, vignette-based study among student pharmacists.

Tata V, Varisco TJ, Du N, Nguyen J, Haghparast P, Thornton JD. Tata V, et al. J Am Pharm Assoc (2003). 2021 May-Jun;61(3):316-324. doi: 10.1016/j.japh.2021.01.010. Epub 2021 Feb 10. J Am Pharm Assoc (2003). 2021. PMID: 33579594

6

Evaluating the feasibility of implementing a prescription drug misuse prevention intervention in the community: a mixed methods study.

Al Rawwad T, Tata V, Wanat MA, Campbell D, Thornton D. Al Rawwad T, et al. Among authors: tata v. BMC Public Health. 2023 Apr 21;23(1):728. doi: 10.1186/s12889-023-15608-9. BMC Public Health. 2023. PMID: 37085838 Free PMC article.

7

Effects of sacubitril-valsartan on remodelling, fibrosis and mitochondria in a murine model of isoproterenol-induced left ventricular dysfunction.

Vergaro G, Del Franco A, Carecci A, Chen YFF, Aimo A, Forini F, Nicolini G, Kusmic C, Faita F, Castiglione V, De Tata V, Pucci A, Musetti V, Burchielli S, Passino C, Emdin M. Vergaro G, et al. Among authors: de tata v. Int J Cardiol. 2024 May 23:132203. doi: 10.1016/j.ijcard.2024.132203. Online ahead of print. Int J Cardiol. 2024. PMID: 38795973 Free article.

8

Sequential Normothermic Regional Perfusion and End-ischemic Ex Situ Machine Perfusion Allow the Safe Use of Very Old DCD Donors in Liver Transplantation.

Torri F, Balzano E, Melandro F, Maremmani P, Bertini P, Lo Pane P, Masini M, Rotondo MI, Babboni S, Del Turco S, Antonelli S, De Tata V, Biancofiore G, Guarracino F, Paolicchi A, De Simone P, Basta G, Ghinolfi D; DCDNet Study Group. Torri F, et al. Among authors: de tata v. Transplantation. 2024 Mar 12. doi: 10.1097/TP.0000000000004963. Online ahead of print. Transplantation. 2024. PMID: 38467592

9

Editorial: Selective and secretory autophagy pathways and molecules in the prevention and treatment of complex endocrine-metabolic diseases of aging.

Vaccaro MI, Gonzalez CD, De Tata V, Quarleri J, Budini MF. Vaccaro MI, et al. Among authors: de tata v. Front Endocrinol (Lausanne). 2023 Jan 18;14:1138630. doi: 10.3389/fendo.2023.1138630. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36742379 Free PMC article. No abstract available.

10

Joint Pain and Arthritis as First Clinical Manifestation of Systemic Amyloidosis and Multiple Myeloma: Case Report and Brief Literature Review.

Mazziotta F, Buda G, Del Giudice ML, Orciuolo E, Benedetti E, Masini M, De Tata V, Galimberti S, Petrini M. Mazziotta F, et al. Among authors: de tata v. Hematol Rep. 2022 Mar 2;14(1):19-23. doi: 10.3390/hematolrep14010004. Hematol Rep. 2022. PMID: 35323175 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

86 results

Search Page